Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 2Hemorrhage 2Sexual Infantilism 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Myoma 1Myofibroma 1Diabetes Insipidus 1Craniopharyngioma 1Blood Loss, Surgical 1Adenomyosis 1

Interventions

Misoprostol 6Uterine Myomectomy 4relugolix 3Tranexamic Acid 3Saline Solution 3Hysterectomy 3dienogest 2carbetocin 2Uterine Artery Embolization 2Tourniquets 2Tablets 2Lidocaine 2Leuprolide 2Hysteroscopy 2Ascorbic Acid 2ulipristal 1telapristone acetate 1remimazolam 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tranylcypromine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myofibroma × Oxytocin × Clear all
NCT06325501 2024-03-22

Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

Cairo University

Phase 3 Unknown
56 enrolled

Hemorrhage, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡